已证实多种药物免疫抑制疗法可以提高重型再生障碍性贫血（简称再障）的生存率。最近有些学者建议用免疫抑制疗法代替骨髓移植作为一线疗法治疗再障。为了评估两种方法的疗效，该文对比了重型再障免疫抑制疗法和骨髓移植疗法的治疗结果。 病人和方法　１９８７年１月～１９９７ A variety of drug immunosuppressive therapy has been confirmed to improve the survival rate of severe aplastic anemia (referred to as aplastic anemia). Some scholars recently suggested that immunosuppressive therapy instead of bone marrow transplantation as first-line therapy for aplastic anemia. In order to evaluate the efficacy of the two methods, this article compares the results of treatment of immunosuppressive aplastic anemia and bone marrow transplantation. Patients and Methods January 1987 ~ 1997